Bernstein Research

In a report published Wednesday, Bernstein Research analyst Robin Bienenstock reiterated a Market Perform rating on Vodafone (NASDAQ: VOD), and raised the price target from $35.50 to $40.00. In the report, Bernstein Research noted, “Operationally and strategically, both AT&T and Vodafone are...

In a report published Wednesday, Bernstein Research analyst Aaron Gal reiterated an Outperform rating on Momenta Pharmaceuticals (NASDAQ: MNTA), and raised the price target from $20.00 to $24.00. In the report, Bernstein Research noted, “Momenta missed consensus expectations (-50c, -2c) on lower...

In a report published Tuesday, Bernstein Research analyst Todd Juenger reiterated an Outperform rating on Discovery Communications (NASDAQ: DISCA), and raised the price target from $98.00 to $103.00. In the report, Bernstein Research noted, “Last Thursday, Discovery reported another typical...

In a report published Tuesday, Bernstein Research analyst John E. McDonald reiterated a Market Perform rating and $15.00 price target on Bank of America (NYSE: BAC). In the report, Bernstein Research noted, “In this report, we update our review of Bank of America's legal issues following 3Q13...

In a report published Tuesday, Bernstein Research analyst Derrick Sung downgraded the rating on St. Jude Medical (NYSE: STJ) from Outperform to Market Perform, and lowered the price target from $64.00 to $62.00. In the report, Bernstein Research noted, “We are downgrading St. Jude Medical to...

In a report published Friday, Bernstein Research analyst Pierre Ferragu recommended to stay away from Alcatel-Lucent, S.A. (NYSE: ALU) due to unattractive risk after earnings report. Alcatel-Lucent's revenue came in at 2 percent above consensus and 4 percent above Bernstein's estimates. Ferragu...

In a report published Tuesday, Bernstein Research analyst Stacy A. Rasgon reiterated an Outperform rating and $30.00 price target on Broadcom Corporation (NASDAQ: BRCM). In the report, Bernstein Research noted, “We believe investors should be disappointed with Broadcom's management and Board of...

In a report published Tuesday, Bernstein Research analyst Scott Gruber reiterated an Outperform rating on Schlumberger Limited (NYSE: SLB), and raised the price target from $97.00 to $112.00. In the report, Bernstein Research noted, “Coming into 2013, our primary positioning call was to be...

In a report published Tuesday, Bernstein Research analyst Scott Gruber reiterated an Outperform rating on Halliburton Company (NYSE: HAL), and raised the price target from $55.00 to $69.00. In the report, Bernstein Research noted, “Coming into 2013, our primary positioning call was to be...

In a report published Tuesday, Bernstein Research analyst Scott Gruber reiterated an Outperform rating on Baker Hughes (NYSE: BHI), and raised the price target from $62.00 to $73.00. In the report, Bernstein Research noted, “Coming into 2013, our primary positioning call was to be overweight in...

In a report published Tuesday, Bernstein Research analyst Stacy A. Rasgon downgraded the rating on Advanced Micro Devices (NYSE: AMD) from Market Perform to Underperform, and lowered the price target from $3.00 to $2.50. In the report, Bernstein Research noted, “We promised ourselves once upon a...

In a report published Friday, Bernstein Research analyst Stacy Rasgon decreased estimates on Advanced Micro Devices (NYSE: AMD) and lowered the PT from $4 to $3 after 3Q13 results. Advanced Micro Devices reported 3Q13 results yesterday after the closing bell. AMD's results were up 25.8%QoQ at $1...

In a report published Monday, Bernstein Research analyst Tim Anderson downgraded the rating on Merck & Co. (NYSE: MRK) from Outperform to Market Perform, and lowered the price target from $53.00 to $50.00. In the report, Bernstein Research noted, “We are downgrading Merck to Market-Perform...

Salesforce (NYSE: CRM) is soaring after announcing impressive second quarter results and full-year estimates that are in-line with Wall Street. The popular cloud computing company reported a Q2 EPS of $0.09. This was 18 percent lower than the EPS reported during the year-ago period, but it was...

In a report published Wednesday, Bernstein Research analyst Mark L. Moerdler reiterated an Underperform rating and $29.00 price target on salesforce.com (NYSE: CRM). In the report, Bernstein Research noted, “Salesforce.com's stock prices-in sustained strong growth and significant margin expansion...